Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Aug 15;200(4):410-412.
doi: 10.1164/rccm.201901-0233ED.

Fail-Fast in Respiratory Syncytial Virus Vaccine Development

Sjanna B Besteman  1 , Louis J Bont  1
Affiliations
Comment

Fail-Fast in Respiratory Syncytial Virus Vaccine Development

Sjanna B Besteman et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Mazur NI, Higgins D, Nunes MC, Melero JA, Langedijk AC, Horsley N, et al. Respiratory Syncytial Virus Network (ReSViNET) Foundation. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. Lancet Infect Dis. 2018;18:e295–e311. - PubMed
    1. Novavax announces topline RSV F vaccine data from two clinical trials in older adults 5. Gaithersburg, MD: Novavax; 2016 [accessed 2019 Jan 28]. Available from: http://ir.novavax.com/news-releases/news-release-details/novavax-announc....
    1. Novavax reaches significant enrollment milestone in the prepare(TM) phase 3 trial of its RSV F vaccine. Gaithersburg, MD: Novavax; 2018 [accessed 2019 Jan 28]. Available from: http://ir.novavax.com/news-releases/news-release-details/novavax-reaches....
    1. Khanna R, Guler I, Nerkar A. Fail often, fail big, and fail fast? Learning from small failures and R&D performance in the pharmaceutical Industry. Acad Manag J. 2015;59:436–459.
    1. Ascough S, Vlachantoni I, Kalyan M, Haijema B-J, Wallin-Weber S, Dijkstra-Tiekstra M, et al. Local and systemic immunity against respiratory syncytial virus induced by a novel intranasal vaccine: a randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med. 2019;200:481–492. - PMC - PubMed

MeSH terms

Substances